Kylin Therapeutics Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 6

Kylin Therapeutics General Information

Description

Operator of a biotechnology company. The company employs a RNA nanoparticle technology platform called pRNA to utilize the potential of RNA interference (RNAi) for treatment of cancer and cancer related diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Acquirer
Guangzhou Biomotor and RNA Nanotech Development Company
Primary Office
  • 3000 Kent Avenue
  • West Lafayette, IN 47906
  • United States
+1 (765) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kylin Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kylin Therapeutics‘s full profile, request access.

Request a free trial

Kylin Therapeutics Board Members (3)

Name Representing Role Since
00000 000000 Self Board Member 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Kylin Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kylin Therapeutics‘s full profile, request access.

Request a free trial